To further determine the cross-talk between STING agonist and TCR-T cells in vivo, we evaluated the antitumor effects of diABZI and 1G4 TCR-T cells in a Mel526 tumor-bearing NCG mouse model (Fig. 7A). The gene discussed is STING1; the disease is neoplasm.